SORRENTO THERAPEUTICS, INC.: cash_and_restricted_cash

Value{"amount": 36665000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"}
Period (as of 2021-12-31)
Statuscurrent
EntitySORRENTO THERAPEUTICS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0000950170-22-003472 · Open the official SEC filing →
Retrieved: 2026-08-19T08:26:07.310866+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000850261/cash-and-restricted-cash/2021-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/817bfa74-2359-4e29-a3c0-a5b7e0925dbb

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies